We are live on ! Find out more
CVSC

C.V. Starr & Co Portfolio holdings

AUM $192M
1-Year Est. Return 35.69%
This Fund
S&P 500
This Quarter Est. Return
+5.91%
1 Year Est. Return
+35.69%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$192M
AUM Growth
+$9.79M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLD icon
1
SPDR Gold Trust
GLD
$132B
$108M 56.41%
251,400
IDEV icon
2
iShares Core MSCI International Developed Markets ETF
IDEV
$31.3B
$31.7M 16.51%
378,787
IVOO icon
3
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.74B
$26M 13.56%
227,427
IJR icon
4
iShares Core S&P Small-Cap ETF
IJR
$110B
$24.9M 12.99%
200,458
CELU icon
5
Celularity
CELU
$21.7M
$1.02M 0.53%
764,069

Similar funds

C.V. Starr & Co's Q1 2026 Portfolio in Review

As of Q1 2026, C.V. Starr & Co held 5 positions worth $192M, up 5.4% from $182M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2026: portfolio turnover was 0%. C.V. Starr & Co opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 0.53% of assets, down from 0.87% a quarter earlier.

  • C.V. Starr & Co's ten largest holdings make up 100% of its $192M portfolio in Q1 2026.
  • C.V. Starr & Co opened 0 new positions and closed 0 in Q1 2026.
  • C.V. Starr & Co's portfolio value rose 5.4% quarter-over-quarter to $192M.

Based on C.V. Starr & Co's 13F filing for Q1 2026, filed 11 May 2026.